In-Depth

The In-Depth page consists of Insight Articles, Commentaries, C-level Q&As, Discussion Group Reports, and Survey Reports.

Discussion Group Report
Digital health is often seen as the 'next big thing' but there are challenges ahead. This month, our discussion group focused on fragmentation, data flow, protection and regulatory approval.
By Oliver Picken |
05 May 2022
Pharma Data
Commentary
This Commentary article revisits the development and implementation of mobile health data, exploring how initiatives such as the NHS track and trace system helped to mitigate the worst of the impact of the Covid-19 pandemic. Here, we consider the applications of mHealth data for present and future pandemic situations.
By Ben Norris |
26 April 2022
Pharma Data
Insight Article
Can digital biomarkers provide valuable data and hasten to process of drug discovery?
By Oliver Picken |
25 April 2022
Pharma Data
Commentary
This Commentary piece looks at the means by which the global approval process for new medicines can be sped up through the controlled use of FAIR data. Key areas of focus include the sharing of healthcare data to bring the patient voice within the clinical setting.
By Ben Norris |
28 March 2022
Pharma Data
Discussion Group Report
Key opinion leaders discuss the latest trends and challenges in laboratory automation and digitalization. Key insights include an explanation of Roche's 'Levers of Production' method, the challenges of legacy systems and the possibility of digitalization overload.
By Oliver Picken |
21 March 2022
SmartLabs
Insight Article
The pharmaceutical industry is working on improving the usability of automation platforms but challenges remain.
By Oliver Picken |
10 March 2022
SmartLabs
Discussion Group Report
This November, our PharmaTec Series discussion group focused on mobile robotics. We explored their current uses, challenges and potential.
By Oliver Picken |
10 February 2022
PharmaTec Series
Insight Article
Digital tools to boost productivity and optimise pharma manufacturing are becoming increasingly prevalent through smart sensors, AI, ML, virtual reality, and cloud computing. Digital transformation is here for Pharma, and it is changing companies' priorities towards digital solutions.  
By Oliver Picken |
04 February 2022
AI & Machine Learning
Commentary
Dr Boris Adryan, Digital & Data Capability Building Lead at Merck Healthcare KGaA, teaches the company’s workforce the importance of data.
By Tom Cohen |
17 January 2022
Pharma Data
Insight Article
The amount of data created by pharmaceutical companies has increased exponentially over the last few decades. Managing these enormous volumes of data can be challenging, an issue compounded by a lack of standardisation. Data is often gathered from numerous sources and devices and stored separately, making it difficult to retrieve, query, share and analyse. 
By Oliver Picken |
18 November 2021
Pharma Data
Discussion Group Report
This September, our PharmaTec series discussion group focused on cutting edge data analytics. Some of the key topics our experts covered included whether analytics should start with the data or a use case first, different analytical platforms and the application of AI/ML technologies.  
By Oliver Picken |
18 November 2021
Pharma Data
Commentary
The foundation of any 21st century smart lab is data management and connectivity.
By Oliver Picken |
12 October 2021
SmartLabs
Commentary
How can pharma companies harness the power of data using innovative technologies?
By Oliver Picken |
04 September 2021
Pharma Data
Insight Article
What is being done to overcome difficulties with supply chains, regulatory processes, and scalability?
By Oliver Picken |
21 August 2021
Lab Automation
Insight Article
Brian Martin, Head of AI in R&D Information Research, Senior Principal Data Scientist, AbbVie
25 September 2019
AI & Machine Learning
Insight Article
Ignacio Quiles Lara, Global Marketing & Commercial Operations, AbbVie
25 September 2019
Pharma Data
Insight Article
Oliver De Peyer, Senior Laboratory Research Scientist, The Francis Crick Institute
25 September 2019
SmartLabs
Insight Article
Nigel Hughes, Scientific Director, Janssen Pharma R&D
11 September 2014
Pharma Data
Advertisement

We produce cutting edge congresses and summits for the Life Sciences Industry, bringing together industry leaders and solution providers at a senior level, creating the opportunity to partner, network and knowledge share.

Contact Us:

Copyright Oxford Global Marketing Limited. All rights reserved.

Member Community Login